NCT00444717
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Inflammation, +7 more
- Locations
-
- Tatsuaki Matsubara Nagoya, Aichi-ken, Japan
Clinical trial condition
Insulin Resistance
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
1,366 public trials
160 recruiting studies
Insulin Resistance trial results
NCT00395486
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +4 more
- Locations
-
- Research Site Pusan, South Korea
- Research Site Seoul, South Korea
- Research Site Suwon, South Korea
NCT00140816
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Heart Disease, +7 more
- Locations
-
- Lipidklinikken, Medisinsk avdeling, Rikshospitalet Oslo, Norway
NCT00314561
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- Korea University Anam Hospital Seoul, South Korea
NCT00230919
- Conditions
- Body Weight, Body Weight Changes, Glucose Metabolism Disorders, +12 more
- Locations
-
- Ulleval University Hospital, dep. of preventive cardiology Oslo, Norway
Completed
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)
NCT00416741
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes Mellitus, +18 more
- Locations
-
- Hellenic Atherosclerosis Society Thessaloniki, Greece
Completed
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
NCT00711737
- Conditions
- Anxiety Disorders, Depressive Disorder, Depressive Disorder, Major, +11 more
- Locations
-
- Changi General Hospital Singapore
Completed
Weight Loss Improves Renal Hemodynamics
NCT01356394
- Conditions
- Body Weight, Chronic Disease, Chronic Kidney Disease, +22 more
- Locations
-
- NIEPEN Juiz de Fora, Minas Gerais, Brazil
NCT00664742
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Götzepe Education and Research Hospital Istanbul, Turkey (Türkiye)
Completed
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +19 more
- Locations
-
- Bambino Gesù Hospital and Research Institute Rome, Italy